MedTrace Logo

Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms

NCT03624712 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 580

Last updated 2025-01-17

No results posted yet for this study

Summary

Evaluation of clinical, therapeutic and prognostic relevance of new experimental results as well as optimization of therapeutic models and development of a new algorithm for therapeutic plan and therapy in patients with uterine neoplasm

Conditions

  • Uterine Neoplasms

Interventions

DIAGNOSTIC_TEST

uterine neoplasms

Analysis of circulating (CTC) and disseminating tumor cells (DTC), determination of Human Papilloma Virus (HPV), Douglas cytology, DNA analysis in blood, proteome analysis, sentinel lymph node detection

Sponsors & Collaborators

  • University Hospital Heidelberg

    collaborator OTHER

  • University of Homburg

    collaborator OTHER

  • University Hospital Freiburg

    collaborator OTHER

  • University Hospital Tuebingen

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03624712 on ClinicalTrials.gov